Skip to main content

Aroa Silgado Gimenez

I am a postdoctoral researcher at Internacional Health Unit of the Microbiology group at Vall d'Hebron Research Institute (VHIR).

Institutions of which they are part

Postdoctoral researcher
Microbiology
Vall Hebron Institut de Recerca
Aroa Silgado Gimenez

Aroa Silgado Gimenez

Aroa Silgado Gimenez

Institutions of which they are part

Postdoctoral researcher
Microbiology
Vall Hebron Institut de Recerca

I am a postdoctoral researcher at Internacional Health Unit of the Microbiology group at Vall d'Hebron Research Institute (VHIR).

I am graduated in Biology at the University of Girona. I extended my studies with a master's degree in microbiology at the Autonomous University of Madrid. In 2018 I started my research career, which culminated with the title of Doctor in Microbiology at the Autonomous University of Barcelona in 2022.
My research career is focused on the study of different parasites that cause various diseases in humans, mainly Trypanosoma cruzi and Leishmania spp.

Projects

PILOT PROJECT FOR THE SCREENING OF CHAGAS DISEASE IN COMMUNITY PHARMACIES

IP: Ines Mercedes Oliveira Souto
Collaborators: Susana Otero Romero, Israel Molina Romero, Fernando M Salvador Velez, Jordi Gómez i Prat, Adrián Sánchez Montalvá, Elena Sulleiro Igual, Aroa Silgado Gimenez
Funding agency: Fundació La Marató de TV3
Funding: 121150
Reference: 20182610
Duration: 10/05/2019 - 31/01/2023

ZIKAction: Preparedness, research and action network on maternal-paediatric axis of ZIKV infection in Latin America and the Caribbean

IP: Pere Soler Palacín
Collaborators: Antoni Soriano Arandes, Aroa Silgado Gimenez, Elena Sulleiro Igual, Antoni Soriano Arandes, Antoni Soriano Arandes, Antoni Soriano Arandes, Antoni Soriano Arandes, Maria Espiau Guarner
Funding agency: EUROPEAN COMMISSION
Funding: 313338.28
Reference: ZIKACTION_H2020SC1-2016
Duration: 01/10/2016 - 30/09/2021

Related news

The new diagnostic method, designed for use in endemic regions, combines a mobile application with a low-cost robotic microscope.

The European network EUPertStrain celebrates its annual meeting, focused on the study of the evolution of Bordetella pertussis, the bacterium responsible for this disease that can be very serious in children under one year.

The Vall d'Hebron work has shown that people vaccinated with Pfizer or Moderna have specific memory T lymphocytes against SARS-CoV-2 in the lung months after vaccination.

Related professionals

Berta Caralt Ramisa

Berta Caralt Ramisa

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Laura Ludovica Gramegna .

Laura Ludovica Gramegna .

Predoctoral researcher
Clinical Neuroimmunology
Read more
Francesc Xavier Serra Marin

Francesc Xavier Serra Marin

Research assistant
Biomedical Research in Gynaecology
Read more
Anna Sole Fores

Anna Sole Fores

Research technician
Donation and transplantation of organs, tissues and cells
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.